Tuesday, June 23, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 983 of 1,261

  1. US 7825102

    Treatment of dry eye conditions

    CAN-FITE BIOPHARMA LTD. · Granted Nov 2, 2010 · Expires Oct 28, 2030

    granted

  2. US 7825154

    Small molecule inhibitors of botulinum neurotoxins

    The United States of America as represented by the Secretary of the Army · Granted Nov 2, 2010 · Expires Oct 28, 2030

    granted

  3. US 7825242

    Dipeptidyl peptidase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Nov 2, 2010 · Expires Oct 28, 2030

    granted

  4. US 7824682

    Cardiac myosin light chain kinase-specific antibodies and methods of detecting

    The United States of America, as represented by the Department of Health and Human Services · Granted Nov 2, 2010 · Expires Oct 28, 2030

    granted

  5. US 7824697

    High concentration baclofen preparations

    The Board of Regents of the University of Texas System · Granted Nov 2, 2010 · Expires Oct 28, 2030

    granted

  6. US 7824680

    Methods for inhibiting angiogenesis

    The Regents of the University of California · Granted Nov 2, 2010 · Expires Oct 28, 2030

    granted

  7. US 7824690

    Marek's disease virus vaccine

    The United States of America, as represented by the Secretary of Agriculture · Granted Nov 2, 2010 · Expires Oct 28, 2030

    granted

  8. US 7825092

    Dendroaspis natriuretic peptide for treatment of cancer

    United States Department of Veteran Affairs · Granted Nov 2, 2010 · Expires Oct 28, 2030

    granted

  9. US 7824695

    Delivery of proteins across polar epithelial cell layers

    The United States of America, as represented by the Department of Health and Human Services · Granted Nov 2, 2010 · Expires Oct 28, 2030

    granted

  10. US 2010273803

    Oral Formulations for Tetrapyrrole Derivatives

    CERAMOPTEC IND INC [DE] · Granted Oct 28, 2010 · Expires Oct 23, 2030

    granted

  11. US 7820663

    Substituted enaminones, their derivatives and uses thereof

    The Regents of the University of California · Granted Oct 26, 2010 · Expires Oct 21, 2030

    granted

  12. US 7820398

    Immunosorbent blood tests for assessing paroxysmal cerebral discharges

    GRACE LABORATORIES, LLC · Granted Oct 26, 2010 · Expires Oct 21, 2030

    granted

  13. US 7820671

    Peptidomimetic protease inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Oct 26, 2010 · Expires Oct 21, 2030

    granted

  14. US 7820685

    Aminopyrimidines useful as kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Oct 26, 2010 · Expires Oct 21, 2030

    granted

  15. US 7820631

    Anti-viral pyrimidine nucleoside analogues

    University College Cardiff Consultants Limited · Granted Oct 26, 2010 · Expires Oct 21, 2030

    granted

  16. US 7820837

    Condensed ring compound

    Takeda Pharmaceutical Company Limited · Granted Oct 26, 2010 · Expires Oct 21, 2030

    granted

  17. US 7820784

    Orally administered peptides synergize statin activity

    The Regents of the University of California · Granted Oct 26, 2010 · Expires Oct 21, 2030

    granted

  18. US 7820819

    2,4-pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Oct 26, 2010 · Expires Oct 21, 2030

    granted

  19. US 7820817

    Modulators of muscarinic receptors

    Vertex Pharmaceuticals Incorporated · Granted Oct 26, 2010 · Expires Oct 21, 2030

    granted

  20. US 7820733

    Dental polymerizable core build-up material of separately packed type

    Kuraray Medical Inc. · Granted Oct 26, 2010 · Expires Oct 21, 2030

    granted

  21. US 7820695

    Selective serotonin receptor inverse agonists as therapeutics for disease

    ACADIA Pharmaceuticals Inc. · Granted Oct 26, 2010 · Expires Oct 21, 2030

    granted

  22. US 7820634

    Composition and method for production of transformed cells

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Oct 26, 2010 · Expires Oct 21, 2030

    granted

  23. US 7820673

    Urea derivative, process for producing the same, and use

    Takeda Pharmaceutical Company Limited · Granted Oct 26, 2010 · Expires Oct 21, 2030

    granted

  24. US 7820642

    Nandrolone 17β-carbonates

    The United States of America, as represented by the Department of Health and Human Services · Granted Oct 26, 2010 · Expires Oct 21, 2030

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.